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▼Partial cDNA clones from the 3′-ends of mRNAs can of-
ten be obtained using a degenerate primer to a conserved
region of a protein in an anchored PCR reaction (Ref. 1).
However, further sequencing requires some formof 5′RACE.
The methods are PCR based and require the addition of a
synthetic priming sequence to the 3′-end of the cDNA. This
is usually done either using the enzyme, terminal deoxynu-
cleotidyl transferase (Ref. 2, 3, 4), or by ligation of a single-
stranded oligonucleotide to the 3′-end of the cDNA using
RNA ligase (Ref. 5). However, we have found the terminal
deoxynucleotidyl transferase enzyme very difficult to use
and the RNA ligase procedure long and complicated and
also unreliable.
In this report we describe a simple technique to obtain 5′-
ends of mRNA by adding an artificial priming site to the 3′-
end of newly synthesized cDNA using T4 DNA ligase (Figure
1). The procedure relies on the fact that DNA–RNA hybrids
can act as substrates for T4 DNA ligase (in fact such hybrid
molecules can be ligated directly into a plasmid vector to
create a library of cDNA clones, although the efficiency is
quite low). In this procedure, newly synthesized cDNA is re-
tained as a cDNA–RNA hybrid. This hybrid is then ligated,
using T4 DNA ligase, to plasmid DNA digested with a re-
striction enzyme that leaves blunt ends. The plasmid DNA
then supplies the external priming sequence for either a T7
primer or M13 sequencing primer. The main advantages of
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this technique is that, unlike previous methods, it is a rapid
two-step procedure.
We have used this technique to obtain the 5′-ends of
several insect mRNA sequences. As reported here, the first-
strand cDNA was synthesized in a normal reaction using a
specific primer complementary to the sequence of interest
(primer A). The reaction contained:
4 µl of 5×AMV reverse transcriptase buffer (Promega) [250
mM Tris-Cl (pH 8.3), 250 mM KCl, 50 mM MgCl2, 2.5
mM spermidine, 50 mM DTT]
0.8 mM dNTPs (Promega)
4 mM sodium pyrophosphate
500 ng of primer
20 U of RNase inhibitor (Progen, Australia)
4–6 µg of poly(A+) RNA or total RNA
10 U of AMV reverse transcriptase (Promega) in a final vol-
ume of 20 µl
The sample was incubated for 1 h at 42◦C. After in-
cubation, the reaction volume was made up to 100 µl
with TE (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) and
RNase A (Sigma) added to give a final concentration of
10 µg/ml. The sample was incubated at room tempera-
ture for 1 hour to make the cDNA–mRNA hybrid blunt
ended. A phenol–chloroform extraction was performed
to inactivate enzymes and the blunt-ended cDNA–RNA
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FIGURE 1. Reaction scheme for the method as described in detail in the methods.
was ethanol precipitated after adding 0.1 volume of 2 M
sodium acetate (pH 4.0) and 10 µg of tRNA as carrier.
After centrifugation at 4◦C the pellet was washed with
100% ethanol, dried and the pellet dissolved in 6.5 µl
of TE.
The next step involved the ligation of the blunt-ended
cDNA–RNA to a plasmid vector digested with Sma I or EcoR
V. The 10 µl reaction contained:
6.5 µl of blunt-ended cDNA–RNA
1 µl of 10×ligation buffer [300 mM Tris-Cl (pH 7.8), 100
mM MgCl2, 100 mM DTT, 5 mM ATP ] (Promega)
100 ng of SmaI cut pGEM-3Z plasmid vector (Promega) or
EcoRV cut Bluescript vector (Stratagene)
3 U of T4 DNA ligase (Promega)
1 U of SmaI or EcoRV restriction enzyme (Promega)
It was incubated at 14–15◦C for 16 hours and then made
up to 30 µl with water. PCR amplification was carried out
in a volume of 50 µl as follows
5 µl of 10×Mg-free Taq polymerase buffer (Promega) (500
mM KCl, 100 mM Tris-Cl (pH 9.0), 1.0% triton X-100
2.5 mM MgCl2
0.4 mM dNTPs
20 ng of each of a sequence-specific complementary primer
(primer b; Figure 1) and T7 primer (5′- GTAATAC-
GACTCACTATAGGGC), or M13 forward primer (5′-
CGCCAGGGTTTTCCCAGTCACGAC)
3 ml ligated cDNA–RNA
2.5 U of Taq DNA polymerase (Promega)
The PCR reaction was carried out using the following
program:
95◦C for 2 min
followed by 30 cycles of
95◦C for 30 sec
56◦C for 30 sec
72◦C for 2 min
and then 72◦C for 5 min
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FIGURE 2. Agarose gel electrophoresis of PCR products (lane 1) and
HindIII cut lambda DNA standards (lane 2). Bands a and b are discussed
in the text. The PCR products were obtained by synthesis of cDNA
from Helicoverpa armigera midgut poly(A+) RNA using a cytochrome
P450 CYP6B2 specific complementary oligonucleotide, followed by
PCR amplification with a sequence specific primer and T7 primer as
indicated in Figure 3.
10 µl of the PCR product was analysed on a 1% agarose
gel to confirm amplification (Figure 2). The remainder of
the PCR product was ethanol precipitated and ligated di-
rectly into pGEM-Teasy vector (Promega) and the plasmid
transformed into XL1-blue bacteria. (PCR products were
not gel purified because, in our experience, gel purification
makes cloning of PCR fragments extremely inefficient).
Results and discussion
Analysis of the PCR products from a typical experiment
showed one fainter band of about 400 bp (Figure 2, lane
1 band a) and a smaller, more intense band of 260 bp
(Figure 2 lane 1 band b). Ligation of the PCR products
into the pGEM-Teasy vector and subsequent transforma-
tion gave both white and blue colonies when grown on
media containing X-gal. Of ten white colonies picked, two
had plasmids with inserts corresponding to the larger PCR
product while the rest contained the smaller product. Se-
quencing of one of the plasmids with the larger insert re-
vealed the sequence given in Figure 3. Note that the in-
sert is missing the ATG of the initiation codon and the 5′
non-coding region of the mRNA, compared with a cDNA
clone isolated from a cDNA library constructed using a
conventional technique (Ref. 6). Comparison with homol-
ogous sequences suggests that the 5′ non-coding region is
about 35 nucleotides long. Although the technique does
not select for bonafide 5′ ends, it is still useful in extend-
ing cDNA sequence towards the 5′ end of mRNAs. The
present example is that for an insect cytochrome P450
(CYP6B2) for which obtaining full length cDNA clones is
difficult, presumably owing to the presence of secondary
structure.
When using this technique, cDNA can bemadewith total
RNA, but better results were obtained when poly (A+) RNA
was used, particularly if the mRNA of interest was rare. We
have found that EcoRV cut plasmid vectors are more effec-
tive compared to SmaI vectors. The technique as described
requires two primers that are highly specific for the cDNA
of interest, one to prime the synthesis of cDNA and the sec-
ond to act as the specific PCR primer. Oligo-dT primer for
initial synthesis of cDNA has also been used successfully in
this technique. It is important to design the second primer
for use in the PCR reaction to have a melting temperature
(Tm) similar to the T7 primer, or M13 forward primer, to
avoid non-specific amplifications. Best results have been
obtained when PCR was performed 5–6◦C below the Tm
of the sequence specific primer. The initial primer used for
cDNA synthesis can be removed from the reaction mix-
ture by passing through a Sephacryl - 400 (Sigma) column
before the RNase A treatment, but was found to be un-
necessary. Although an M13 primer can be used in this
technique, cloning of the PCR product into pGEM-Teasy
vector results in the presence of two binding sites for that
primer, which then prevents its subsequent use for sequenc-
ing. Hence, we have normally used the T7 primer in the PCR
reaction.
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FIGURE 3. Sequence of the cloned PCR product. The complete plasmid insert contained 403 bp including 41 bp of the original pGEM-3Z plasmid that
contained the T7 RNA polymerase promoter site. The PCR primers used corresponded to the sequences in underlined bold. The top two lines show the
amino acid and nucleotide sequences obtained from the 5′ end of the cDNA clone obtained from a conventional cDNA library. The initiation codon was
assigned by comparison to homologous cytochrome P450 sequences.
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Products Used
MMLV and AMV reverse transcriptase: MMLV
and AMV reverse transcriptase from Promega Corpora-
tion
AMV reverse transcriptase: AMV reverse tran-
scriptase from Boehringer Mannheim
Reverse Transcriptase: Reverse Transcriptase
from Boehringer Mannheim
AMV reverse transcriptase: AMV reverse tran-
scriptase from Promega Corporation
dNTP: dNTP from Promega Corporation
dNTP: dNTP from PE Applied Biosystems
dNTP: dNTP from Pharmacia
dNTP: dNTP from Promega Corporation
dNTP: dNTP from Boehringer Mannheim
RNase inhibitor: RNase inhibitor from Life Tech-
nologies (Gibco BRL)
RNase inhibitor: RNase inhibitor from Toyobo
RNase: RNase from Sigma
RNAse inhibitor: RNAse inhibitor from Stratagene
RNase inhibitor: RNase inhibitor from Progen
Rnase inhibitor: Rnase inhibitor from Promega
Corporation
MMLV and AMV reverse transcriptase: MMLV
and AMV reverse transcriptase from Promega Corpora-
tion
AMV reverse transcriptase: AMV reverse tran-
scriptase from Boehringer Mannheim
Reverse Transcriptase: Reverse Transcriptase
from Boehringer Mannheim
AMV reverse transcriptase: AMV reverse tran-
scriptase from Promega Corporation
RNase A: RNase A from QIAGEN GmbH
RNase: RNase from Sigma
RNase A: RNase A from Sigma
ATP: ATP from Boehringer Mannheim
pGEM3z: pGEM3z from Promega Corporation
T4 DNA ligase: T4 DNA ligase from Boehringer
Mannheim
ligase: ligase from Boehringer Mannheim
Sma I: Sma I from Boehringer Mannheim
EcoR V restriction enzyme: EcoR V restriction
enzyme from Promega Corporation
EcoRV: EcoRV from New England BioLabs
EcoRV: EcoRV from Boehringer Mannheim
Taq DNA polymerase: Taq DNA polymerase from
PE Applied Biosystems
Taq DNA polymerase: Taq DNA polymerase from
Life Technologies (Gibco BRL)
Taq DNA polymerase: Taq DNA polymerase from
Life Technologies (Gibco BRL)
Taq DNA polymerase: Taq DNA polymerase from
Promega Corporation
Taq polymerase: Taq polymerase from Boehringer
Mannheim
Taq polymerase: Taq polymerase from Pharmacia
Taq polymerase: Taq polymerase from Bioline
Taq polymerase: Taq polymerase from Advanced
Biotechnologies
Taq polymerase: Taq polymerase from Boehringer
Mannheim
Taq polymerase: Taq polymerase from Bioline
Taq DNA Polymerase: Taq DNA Polymerase from
Boehringer Mannheim
Taq polymerase: Taq polymerase from Pharmacia
Taq polymerase: Taq polymerase from Bioline
Taq polymerase: Taq polymerase from Boehringer
Mannheim
Taq polymerase: Taq polymerase from Boehringer
Mannheim
Taq polymerase: Taq polymerase from Bioline
Taq DNA polymerase: Taq DNA polymerase from
PE Applied Biosystems
Taq DNA Polymerase: Taq DNA Polymerase from
Boehringer Mannheim
Taq DNA polymerase: Taq DNA polymerase from
Life Technologies (Gibco BRL)
Taq DNA polymerase: Taq DNA polymerase from
Promega Corporation
Taq DNA polymerase: Taq DNA polymerase from
Stratagene
Taq DNA polymerase: Taq DNA polymerase from
Takara Shuzo
Taq DNA polymerase: Taq DNA polymerase from
Amersham Pharmacia Biotech
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